GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » EV-to-EBIT

China Medical System Holdings (HKSE:00867) EV-to-EBIT : 3.94 (As of Jun. 09, 2024)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, China Medical System Holdings's Enterprise Value is HK$12,586 Mil. China Medical System Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,194 Mil. Therefore, China Medical System Holdings's EV-to-EBIT for today is 3.94.

The historical rank and industry rank for China Medical System Holdings's EV-to-EBIT or its related term are showing as below:

HKSE:00867' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.43   Med: 12.67   Max: 39.32
Current: 3.94

During the past 13 years, the highest EV-to-EBIT of China Medical System Holdings was 39.32. The lowest was 3.43. And the median was 12.67.

HKSE:00867's EV-to-EBIT is ranked better than
92.68% of 669 companies
in the Drug Manufacturers industry
Industry Median: 16.7 vs HKSE:00867: 3.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. China Medical System Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was HK$28,680 Mil. China Medical System Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,194 Mil. China Medical System Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 11.14%.


China Medical System Holdings EV-to-EBIT Historical Data

The historical data trend for China Medical System Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings EV-to-EBIT Chart

China Medical System Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.59 5.66 6.76 6.05 8.98

China Medical System Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.76 - 6.05 - 8.98

Competitive Comparison of China Medical System Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's EV-to-EBIT falls into.



China Medical System Holdings EV-to-EBIT Calculation

China Medical System Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=12585.804/3193.863
=3.94

China Medical System Holdings's current Enterprise Value is HK$12,586 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical System Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,194 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings  (HKSE:00867) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

China Medical System Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=3193.863/28679.5186
=11.14 %

China Medical System Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was HK$28,680 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical System Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,194 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical System Holdings (HKSE:00867) Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.
Executives
Treasure Sea Limited 2101 Beneficial owner
Lam Kong 2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines